Susanne Clara Bard, UC San Diego Beyond the widespread attention GLP-1 drugs are receiving for treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease, emerging research is investigating their other potential impacts including their effects on aging
For instance, while GLP-1 agonists are primarily metabolised by the kidneys and have a low potential for significant drug-drug interactions, it is still important to monitor patients closely when combining therapies
And youre still responsible for converting leadsmany dont show up
Why Publishers Should Act Now with Yep Ads The GLP-1 surge isnt just about trafficits about revenue
Furuyama W, Marzi A, Carmody AB et al (2016) Fc-receptor IIa-mediated Src signaling pathway is essential for the antibody-dependent enhancement of ebola virus infection
Sarcoma Meta-analysis Collaboration